Corestreet Logo

Crispr Therapeutics AG (CRSP) Insider Trading

Total insider buys:
  • $27,833,805.86
Total insider sells:
  • $315,291,536.43
Most recent insider trade:
  • Nov. 11, 2024
Most active insider trader:
  • Samarth Kulkarni
Trader NameDateTitleAmountPriceTypeTotal Value
Sept. 1, 2020Director60,000$92.51Sell$5,550,600.00
July 7, 2020President25,000$90.00Sell$2,250,000.00
July 6, 2020Director20,000$82.39Sell$1,647,800.00
June 24, 2020COO65,088$75.93Sell$4,942,131.84
June 23, 2020President50,000$75.00Sell$3,750,000.00
June 23, 2020VP7,158$75.04Sell$537,136.32
June 23, 2020Director20,000$73.93Sell$1,478,600.00
June 1, 2020CEO17,275$64.68Sell$1,117,347.00
May 20, 2020CEO10,693$65.28Sell$698,039.04
May 19, 2020President50,000$65.00Sell$3,250,000.00
May 11, 2020COO25,000$60.40Sell$1,510,000.00
Nov. 19, 2019Director7,500$62.00Sell$465,000.00
Nov. 19, 2019President33,618$70.00Sell$2,353,260.00
Nov. 12, 2019Director7,500$55.00Sell$412,500.00
Oct. 30, 2019Director7,500$52.00Sell$390,000.00
July 11, 2019Insider20,000$50.02Sell$1,000,400.00
July 10, 2019President50,000$50.00Sell$2,500,000.00
June 17, 2019CEO20,000$46.00Sell$920,000.00
June 10, 2019President50,000$45.00Sell$2,250,000.00
April 29, 2019CEO20,000$42.03Sell$840,600.00
March 4, 2019President85,220$40.40Sell$3,442,888.00
March 1, 2019President8,693$40.01Sell$347,806.93
Feb. 25, 2019President14,780$40.00Sell$591,200.00
Jan. 8, 2019President17,310$35.09Sell$607,407.90
Dec. 27, 2018Major Shareholder40,198$24.93Buy$1,002,136.14
Dec. 24, 2018Major Shareholder90,742$24.08Buy$2,185,067.36
Dec. 21, 2018Major Shareholder22,742$22.58Buy$513,514.36
Dec. 18, 2018Director72,934$29.85Sell$2,177,079.90
July 5, 2018Director7,500$62.00Sell$465,000.00
July 3, 2018Director5,816$62.00Sell$360,592.00
June 5, 2018Director920$12.51Sell$11,509.20
June 1, 2018CEO15,000$69.36Sell$1,040,400.00
May 17, 2018President75,000$60.00Sell$4,500,000.00
May 14, 2018Director650,000$54.39Sell$35,353,500.00
May 11, 2018Director250,000$52.84Sell$13,210,000.00
May 8, 2018Director128,950$50.39Sell$6,497,790.50
April 30, 2018Director30,566$50.29Sell$1,537,164.14
April 27, 2018Director222,258$50.11Sell$11,137,348.38
April 24, 2018Major Shareholder22,841$50.99Sell$1,164,662.59
April 23, 2018Director101,994$50.68Sell$5,169,055.92
Jan. 16, 2018Insider66,000$28.03Sell$1,849,980.00
Jan. 5, 2018Director92,337$26.96Sell$2,489,405.52
Jan. 5, 2018Major Shareholder527,472$22.75Buy$11,999,988.00
Jan. 2, 2018Director37,754$26.76Sell$1,010,297.04
Jan. 2, 2018Insider38,000$21.64Sell$822,320.00
Dec. 29, 2017Insider31,000$22.72Sell$704,320.00
Dec. 28, 2017Insider700$21.75Sell$15,225.00
Dec. 22, 2017Director3,059$20.29Sell$62,067.11
Dec. 22, 2017Insider15,000$20.55Sell$308,250.00
Dec. 15, 2017Insider15,000$18.90Sell$283,500.00
First«2 of 4»Last

  • Insiders are both buying and selling Crispr Therapeutics AG stock.

  • The insider traders at Crispr Therapeutics AG are: Samarth Kulkarni, Rodger Novak, Kurt Von Emster, Bradley J Phd Bolzon, Corp /De/ Celgene, Tyler Dylan-Hyde, Pablo J Cagnoni, Thomas Woiwode, Lawrence Otto Klein, Vertex Pharmaceuticals (Europe, James R Kasinger, Michael John Tomsicek, Julianne Bruno, Simeon George, James R. Kasinger, Tony W Ho, Tony W. Ho, Bradley J. Phd Bolzon, Versant Venture Capital V, L.P, Raju Prasad, and Aktiengesellschaft Bayer

  • The most active insider trader at Crispr Therapeutics AG is Samarth Kulkarni with 33 trades.

  • Kurt Von Emster has sold the most Crispr Therapeutics AG stock with a total value of $68,130,025.01.

  • Aktiengesellschaft Bayer has bought the most Crispr Therapeutics AG stock with a total value of $23,999,976.00.

  • The most recent insider trade for Crispr Therapeutics AG was on Nov. 11, 2024.

  • The single biggest insider buy for Crispr Therapeutics AG was from Aktiengesellschaft Bayer with a total value of $11,999,988.00 on Jan. 5, 2018.

  • The single biggest insider sell for Crispr Therapeutics AG was from Kurt Von Emster with a total value of $35,353,500.00 on May 14, 2018.